Concepedia

Meiwen Lv

ML

Statistics

Publications

3

Citations

77

H-Index

3

Active since

2021

Affiliations

China Medical University(Current)

First Hospital of China Medical University

Meiwen Lv is an author at China Medical University specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2021–2024

3

Publications

3

Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway

Wen Tian, Xianglin Yang, Yang He et al. · Cell Death and Disease · 2021 · 55 citations · Full text

, , +17

ADGRD1 as a Potential Prognostic and Immunological Biomarker in Non‐Small‐Cell Lung Cancer

Meiwen Lv, Xuelian Li, Wen Tian et al. · BioMed Research International · 2022 · 12 citations · Full text

, , +17

Exosomal miR-130b-3p suppresses metastasis of non-small cell lung cancer cells by targeting DEPDC1 via TGF-β signaling pathway

Meiwen Lv, Xuelian Li, Zheng Chang et al. · International Journal of Biological Macromolecules · 2024 · 10 citations · Full text

, , +17

1–3 of 3